Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,729
Closed -$659K 856
2025
Q2
$659K Buy
+12,729
New +$585K 0.33% 32
2024
Q2
Sell
-230
Closed -$9.21K 1569
2024
Q1
$9.21K Buy
230
+12
+6% +$451 0.01% 1249
2023
Q4
$8.21K Buy
+218
New +$6.66K 0.01% 1176

Other funds holding SNV

EntryPoint Capital's SNV Position: Q3 2025 in Review

EntryPoint Capital sold out of Synovus (SNV) in Q3 2025, closing a stake of 12,729 shares — an estimated $659K sold.

EntryPoint Capital first reported a position in SNV in Q4 2023 and held it in 3 quarters. The position peaked at $659K in Q2 2025. 486 funds tracked by Wall St. Rank hold SNV as of Q3 2025.

  • EntryPoint Capital reported no remaining Synovus position as of Q3 2025 after selling out during the quarter.
  • EntryPoint Capital sold 12,729 Synovus shares in Q3 2025, an estimated $659K.
  • EntryPoint Capital first reported a position in Synovus in Q4 2023 and held it in 3 quarters.
  • EntryPoint Capital's Synovus position peaked at $659K in Q2 2025.
  • 486 funds tracked by Wall St. Rank held Synovus as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.